Final answer:
Doxorubicin, which is listed at a dose of 65mg/m², is a chemotherapy drug that has a high potential to be emetogenic, meaning it can cause significant nausea and vomiting.
Step-by-step explanation:
Among the agents listed with potential to be highly emetogenic, doxorubicin at a dose of 65mg/m² stands out as having this potential. Doxorubicin is a type of chemotherapy medication known for its high emetogenic risk, which means it is likely to cause significant nausea and vomiting. This drug is classified as an anthracycline antibiotic and works by interfering with the DNA inside cancer cells to stop them from growing and dividing. Due to its effect on rapidly dividing cells, doxorubicin is often used in various chemotherapy regimens.